Think it was an incorrectly reported sale. $5.00 plus jump didn't make sense. Think it was corrected. Perhaps some neophyte had buy at market after hours, which threw off the prices.
Revenues driven by recent contracts for the most advanced life saving diagnostics will expand 150 times in the next 24 months. And that is just the beginning!
Millennium Healthcare (MHCC) recently announced newly SIGNED contracts with ACO’s IPA’s and MSO’s to provide exclusive, state-of-the-art, non-invasive cardiovascular and cancer diagnostics to 1,300 locations that will escalate Millennium’s current revenues of $2 million per year to over $300 million per year.
Cardiovascular and cancer diagnostics rolling out to physician’s offices this year.
Revenues will begin rapid growth by year end.
Market size for Millennium Diagnostics is 35,000 primary care offices. The first 1,300 recently contracted with Millennium and the rest are standing in line to sign up with Millennium because:
§ Millenniums program increases physician’s revenues dramatically
§ Millennium’s diagnostics are fully paid by Medicare and are free to patients
§ Millennium’s diagnostics appeal to patients because they are life-saving, fast, painless and highly accurate
§ Millennium’s diagnostics are exclusive from Millennium only
§ The physician pays no up front capital costs
Millennium’s market cap is under $40 million today and shares are selling at under $1.00.
What will this growth do to the price of MHCC shares?
Millennium HealthCare is well positioned for explosive growth that is rarely seen.
Sentiment: Strong Buy
Yellen announced initiating coverage on the biotech industry today with a "sell" recommendation. It knocked hell out of the stocks, includings ALKS. Thanks Janet, it is a lovely buying opportunity.
Nah, news of deals always leaks. the stock would be way up on Thursday if a deal was coming. Besides, who closes a deal on July 4th weekend.
Food safety is an unsolved problem with an estimated 48 million foodborne illnesses occurring each year and costing over $50 billion.
PURE Bioscience is revolutionizing food safety with their heavily patented “SDC” and is positioned to become a leader in the food industry.
SDC has already been tested in several large restaurant chains and the results were significantly superior to all other methods. SDC is a powerful and extremely effective antimicrobial but it is safe to humans and has been granted the EPA’s safest product classification of a category IV.
LARGE RESTAURANT CHAINS are placing reorders that are expected to continue to increase to very sizeable numbers. PURE believes this is a 1.5 billion dollar market and SDC is far ahead of the competition.
Based on meetings with the USDA and the FDA, FOOD PROCESSORS are expected to be using SDC in 2015 to decontaminate produce and meat. SDC will also extend shelf life as well as reduce manufacturers costs. PURE believes this is billion-dollar market.
No other product can do what SDC does and do it safely.
SDC will dominate antimicrobials in hospitals, schools, homes, offices, markets, public places, cruise ships, airplanes, trains, personal products like soaps and everywhere the public gathers. Antimicrobial market for disease protection such as influenza, MRSA, etc. is another multi-billion dollar market
SDC is perfectly safe and it continues to kill dangerous pathogens for 24 hours EVEN AFTER IT DRIES.
PURE Bioscience is on the verge of delivering very large and fast growing revenues beginning this year and shares are trading between $1.10 and $1.20 with a very small market cap of $32 million.
All this information can be confirmed on YAHOO FINANCE under “PURE”
PURE is a Strong Buy and Hold
Sentiment: Strong Buy
I agree!! I'm in ALKS for a buyout!! Less than $7 billion market cap is a bargain compared to AZN $80 Billion .
NO BODY IS SELLING ALKS TODAY!! Only about 150K shares when the average daily volume is closer to 1.3 million. Weak hands are selling today on this low volume day. ALKS is headquartered in Ireland, market cap of less than $7 billion, pipeline of drugs coming... some big cap pharm company is going to make a buy to move headquartered to Ireland for the meager 12.5% corporate tax rate !!